Class I - Dangerous
Marketed Without an Approved NDA/ANDA: FDA analysis found product to contain sibutramine and phenolphthalein
Marketed Without an Approved NDA/ANDA: FDA analysis found product to contain sibutramine and phenolphthalein
Marketed Without an Approved NDA/ANDA: FDA analysis found product to contain sibutramine and phenolphthalein